Good Lifestyle

In April, Pfizer andStudes released from Moderna which showed the company's vaccinescontinue to provide strong protection of COVID for at least six months after total vaccination. Meanwhile, people who received Johnson & Johnson Jab patiently waited for their protection against the virus over time. Now, two months after Pfizer and Moderna have published their conclusions, Johnson & Johnson has just published a statement that quotes new research on the continued effectiveness of its vaccine.

RELATED:If you have received this vaccine, you may never need a reminder, a new study indicates.

Given that the three vaccines approved for use in the United States are all relatively new, we had to wait for data on their effectiveness over time. As more time passes, however, researchers are able to better understand how vaccines work and finally years after vaccination.

According to Johnson & Johnson's recent statement, the data show that the "sustainability of the immune response [of the Johnson & Johnson Vaccine] lasted throughat least eight months, the duration has been evaluated to date. "The data will continue to be collected beyond eight months to see if the vaccine remains of protection for even longer.

Significantly, research shows that Johnson & Johnson vaccine has become more protective over time.Mathai Mammen, PhD, World Responsible for Janssen Research & Development, stated in the statement that "vaccine generates a strong response from neutralizing antibodies that did not put an improvement over time. In addition, we observe Persistence and particularly robust, sustainable cellular immune response. "

RELATED:For more information up to date, sign up for our daily newsletter.

And for those who are worried about the delta variant and rapid spread, Johnson & Johnson noted in his statement that the research shows that the vaccine "generated a strong and persistent activity against the variant of Delta and others Variants very widespread.

"We believe that our vaccine provides sustainable protection against Covid-19 and a neutralizing activity against the Delta variant,"Paul Stoffels, MD, Vice-Chairman of the Johnson Executive Committee and Scientific Director, said in the Declaration. "This adds to the robust clinical data body that supports the ability of our unique vaccine to protect against many variations of concern." According to the declaration, these two studies have been subject to printed in Biorxiv.

While a handful of experts suggested that people who have obtained the Johnson & Johnson vaccine by consideringBoostOthers believe that it would be an unnecessary precaution. During a White House Press Briefing July 1, Covid Councilor of the White HouseAnthony Fauci, MD, guaranteeing the effectiveness of the Johnson & Johnson vaccine. "As for the idea of ​​stimulating, there are a lot of discussion about this, but right now, I think we must always remember that the J & J vaccine is aVery efficient vaccine This has been very clearly recommended and has received an emergency authorization, "said Fauci.

RELATED:This only thing reduces antibodies after vaccination - and 6 million people do it.